|
|
 |
|
| | |
| | | | | |
organism-gene
|
|
PR:P05155 |
plasma protease C1 inhibitor (human)
|
hSERPING1
|
"A plasma protease C1 inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P05155-1 |
plasma protease C1 inhibitor isoform h1 (human)
|
hSERPING1/iso:h1
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-1." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P05155-2 |
plasma protease C1 inhibitor isoform h2 (human)
|
hSERPING1/iso:h2
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-2." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P05155-3 |
plasma protease C1 inhibitor isoform h3 (human)
|
hSERPING1/iso:h3
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-3." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000049210 |
plasma protease C1 inhibitor, signal peptide removed form (human)
|
hSERPING1/SigPep-
|
"A plasma protease C1 inhibitor (human) that has had the signal peptide removed. UniProtKB:P05155, 23-500." [PRO:DNx, Reactome:R-HSA-139868, Reactome:R-HSA-158296]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060388 |
plasma protease C1 inhibitor sequence variant L177P, signal peptide removed form (human)
|
hSERPING1/var:L177P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-177 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-177, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650574]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060408 |
plasma protease C1 inhibitor sequence variant A456E, signal peptide removed form (human)
|
hSERPING1/var:A456E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Ala-456 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-456, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650569]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060429 |
plasma protease C1 inhibitor sequence variant Q338*, signal peptide removed form (human)
|
hSERPING1/var:Q338*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-337 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-337." [PRO:DNx, Reactome:R-HSA-9651424]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060501 |
plasma protease C1 inhibitor sequence variant V288E, signal peptide removed form (human)
|
hSERPING1/var:V288E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Val-288 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-288, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650415]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060546 |
plasma protease C1 inhibitor sequence variant I462S, signal peptide removed form (human)
|
hSERPING1/var:I462S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Ile-462 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-462, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650446]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060778 |
plasma protease C1 inhibitor sequence variant F225*, signal peptide removed form (human)
|
hSERPING1/var:F225*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Ile-224 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-224." [PRO:DNx, Reactome:R-HSA-9651381]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000060960 |
plasma protease C1 inhibitor sequence variant V473M, signal peptide removed form (human)
|
hSERPING1/var:V473M/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Met residue at the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-473, CHEBI:16044." [PRO:DNx, Reactome:R-HSA-9650331]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061036 |
plasma protease C1 inhibitor sequence variant T467P, signal peptide removed form (human)
|
hSERPING1/var:T467P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Thr-467 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-467, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650562]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061104 |
plasma protease C1 inhibitor sequence variant Q484*, signal peptide removed form (human)
|
hSERPING1/var:Q484*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-483 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-483." [PRO:DNx, Reactome:R-HSA-9650410]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061229 |
plasma protease C1 inhibitor sequence variant G493R, signal peptide removed form (human)
|
hSERPING1/var:G493R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650561]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061277 |
plasma protease C1 inhibitor sequence variant L481R, signal peptide removed form (human)
|
hSERPING1/var:L481R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651451]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061318 |
plasma protease C1 inhibitor sequence variant A458V, signal peptide removed form (human)
|
hSERPING1/var:A458V/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Val residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30015." [PRO:DNx, Reactome:R-HSA-9650402]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061510 |
plasma protease C1 inhibitor sequence variant I196N, signal peptide removed form (human)
|
hSERPING1/var:I196N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Ile-196 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-196, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9651390]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061553 |
plasma protease C1 inhibitor sequence variant Y496*, signal peptide removed form (human)
|
hSERPING1/var:Y496*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-495 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-495." [PRO:DNx, Reactome:R-HSA-9650355]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061573 |
plasma protease C1 inhibitor sequence variant N291H, signal peptide removed form (human)
|
hSERPING1/var:N291H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Asn-291 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Asn-291, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650545]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061585 |
plasma protease C1 inhibitor sequence variant P476L, signal peptide removed form (human)
|
hSERPING1/var:P476L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Pro-476 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-476, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650563]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061662 |
plasma protease C1 inhibitor sequence variant G184R, signal peptide removed form (human)
|
hSERPING1/var:G184R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650424]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061680 |
plasma protease C1 inhibitor sequence variant P498R, signal peptide removed form (human)
|
hSERPING1/var:P498R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650544]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061855 |
plasma protease C1 inhibitor sequence variant F236S, signal peptide removed form (human)
|
hSERPING1/var:F236S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Phe-236 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Phe-236, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650538]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000061929 |
plasma protease C1 inhibitor sequence variant R466C, signal peptide removed form (human)
|
hSERPING1/var:R466C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650553]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062268 |
plasma protease C1 inhibitor sequence variant R466S, signal peptide removed form (human)
|
hSERPING1/var:R466S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650572]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062279 |
plasma protease C1 inhibitor sequence variant A458T, signal peptide removed form (human)
|
hSERPING1/var:A458T/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Thr residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30013." [PRO:DNx, Reactome:R-HSA-9650554]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062324 |
plasma protease C1 inhibitor sequence variant W482*, signal peptide removed form (human)
|
hSERPING1/var:W482*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-481." [PRO:DNx, Reactome:R-HSA-9650502]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062491 |
plasma protease C1 inhibitor sequence variant P498S, signal peptide removed form (human)
|
hSERPING1/var:P498S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650568]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062550 |
plasma protease C1 inhibitor sequence variant G345R, signal peptide removed form (human)
|
hSERPING1/var:G345R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-345 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-345, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651385]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062579 |
plasma protease C1 inhibitor sequence variant R494*, signal peptide removed form (human)
|
hSERPING1/var:R494*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-493." [PRO:DNx, Reactome:R-HSA-9650555]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062615 |
plasma protease C1 inhibitor sequence variant Q474*, signal peptide removed form (human)
|
hSERPING1/var:Q474*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-473." [PRO:DNx, Reactome:R-HSA-9650547]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000062857 |
plasma protease C1 inhibitor sequence variant L481P, signal peptide removed form (human)
|
hSERPING1/var:L481P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9651448]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000063441 |
plasma protease C1 inhibitor sequence variant P489R, signal peptide removed form (human)
|
hSERPING1/var:P489R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-489 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-489, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650330]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000063530 |
plasma protease C1 inhibitor sequence variant R400C, signal peptide removed form (human)
|
hSERPING1/var:R400C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-400 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-400, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650511]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000063553 |
plasma protease C1 inhibitor sequence variant S318*, signal peptide removed form (human)
|
hSERPING1/var:S318*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asn-317 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-317." [PRO:DNx, Reactome:R-HSA-9651387]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000063798 |
plasma protease C1 inhibitor sequence variant T189N, signal peptide removed form (human)
|
hSERPING1/var:T189N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Thr-189 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-189, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9650346]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000063908 |
plasma protease C1 inhibitor sequence variant S170P, signal peptide removed form (human)
|
hSERPING1/var:S170P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Ser-170 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ser-170, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650362]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000064158 |
plasma protease C1 inhibitor sequence variant G493E, signal peptide removed form (human)
|
hSERPING1/var:G493E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650548]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000064313 |
plasma protease C1 inhibitor sequence variant G184E, signal peptide removed form (human)
|
hSERPING1/var:G184E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650527]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000064435 |
plasma protease C1 inhibitor sequence variant R466H, signal peptide removed form (human)
|
hSERPING1/var:R466H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650560]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000064491 |
plasma protease C1 inhibitor sequence variant R466L, signal peptide removed form (human)
|
hSERPING1/var:R466L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650436]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053466 |
plasma protease C1 inhibitor N-glycosylated 1 (human)
|
hSERPING1/NGlyco:1
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053467 |
plasma protease C1 inhibitor N-glycosylated 2 (human)
|
hSERPING1/NGlyco:2
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G08293MJ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053468 |
plasma protease C1 inhibitor N-glycosylated 3 (human)
|
hSERPING1/NGlyco:3
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G12580WI." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053469 |
plasma protease C1 inhibitor N-glycosylated 4 (human)
|
hSERPING1/NGlyco:4
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G42358LZ." [GlyGen:P05155-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053470 |
plasma protease C1 inhibitor N-glycosylated 5 (human)
|
hSERPING1/NGlyco:5
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G59626AS." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053471 |
plasma protease C1 inhibitor N-glycosylated 6 (human)
|
hSERPING1/NGlyco:6
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G85740DB. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G85740DB." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053472 |
plasma protease C1 inhibitor N-glycosylated 7 (human)
|
hSERPING1/NGlyco:7
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053473 |
plasma protease C1 inhibitor N-glycosylated 8 (human)
|
hSERPING1/NGlyco:8
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G06247RL." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053474 |
plasma protease C1 inhibitor N-glycosylated 9 (human)
|
hSERPING1/NGlyco:9
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G08293MJ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053475 |
plasma protease C1 inhibitor N-glycosylated 10 (human)
|
hSERPING1/NGlyco:10
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G10486CT." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053476 |
plasma protease C1 inhibitor N-glycosylated 11 (human)
|
hSERPING1/NGlyco:11
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G12580WI." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053477 |
plasma protease C1 inhibitor N-glycosylated 12 (human)
|
hSERPING1/NGlyco:12
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G27947YN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053478 |
plasma protease C1 inhibitor N-glycosylated 13 (human)
|
hSERPING1/NGlyco:13
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G36670VW. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G36670VW." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053479 |
plasma protease C1 inhibitor N-glycosylated 14 (human)
|
hSERPING1/NGlyco:14
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G43417UB." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053480 |
plasma protease C1 inhibitor N-glycosylated 15 (human)
|
hSERPING1/NGlyco:15
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G59626AS." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053481 |
plasma protease C1 inhibitor N-glycosylated 16 (human)
|
hSERPING1/NGlyco:16
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G85144OK." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053482 |
plasma protease C1 inhibitor N-glycosylated 17 (human)
|
hSERPING1/NGlyco:17
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G88374WZ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053483 |
plasma protease C1 inhibitor N-glycosylated 18 (human)
|
hSERPING1/NGlyco:18
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053484 |
plasma protease C1 inhibitor N-glycosylated 19 (human)
|
hSERPING1/NGlyco:19
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G06247RL." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053485 |
plasma protease C1 inhibitor N-glycosylated 20 (human)
|
hSERPING1/NGlyco:20
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G88374WZ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053486 |
plasma protease C1 inhibitor N-glycosylated 21 (human)
|
hSERPING1/NGlyco:21
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G94917XT." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053487 |
plasma protease C1 inhibitor N-glycosylated 22 (human)
|
hSERPING1/NGlyco:22
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-69 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G11115RO. Example: UniProtKB:P05155-1, Asn-69, MOD:00160~GNO:G11115RO." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053488 |
plasma protease C1 inhibitor N-glycosylated 23 (human)
|
hSERPING1/NGlyco:23
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-69 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P05155-1, Asn-69, MOD:00160~GNO:G27947YN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053489 |
plasma protease C1 inhibitor O-glycosylated 1 (human)
|
hSERPING1/OGlyco:1
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-113 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Ser-113, MOD:00002~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053490 |
plasma protease C1 inhibitor O-glycosylated 2 (human)
|
hSERPING1/OGlyco:2
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-28 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-28, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053491 |
plasma protease C1 inhibitor O-glycosylated 3 (human)
|
hSERPING1/OGlyco:3
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-28 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P05155-1, Ser-28, MOD:00002~GNO:G58001LT." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053492 |
plasma protease C1 inhibitor O-glycosylated 4 (human)
|
hSERPING1/OGlyco:4
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-30, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053493 |
plasma protease C1 inhibitor O-glycosylated 5 (human)
|
hSERPING1/OGlyco:5
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-31 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G36670VW. Example: UniProtKB:P05155-1, Ser-31, MOD:00002~GNO:G36670VW." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053494 |
plasma protease C1 inhibitor O-glycosylated 6 (human)
|
hSERPING1/OGlyco:6
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-31 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-31, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053495 |
plasma protease C1 inhibitor O-glycosylated 7 (human)
|
hSERPING1/OGlyco:7
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-115 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-115, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053496 |
plasma protease C1 inhibitor O-glycosylated 8 (human)
|
hSERPING1/OGlyco:8
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-118 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-118, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053497 |
plasma protease C1 inhibitor O-glycosylated 9 (human)
|
hSERPING1/OGlyco:9
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-118 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-118, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053498 |
plasma protease C1 inhibitor O-glycosylated 10 (human)
|
hSERPING1/OGlyco:10
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-119 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-119, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053499 |
plasma protease C1 inhibitor O-glycosylated 11 (human)
|
hSERPING1/OGlyco:11
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G29068FM." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053500 |
plasma protease C1 inhibitor O-glycosylated 12 (human)
|
hSERPING1/OGlyco:12
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053501 |
plasma protease C1 inhibitor O-glycosylated 13 (human)
|
hSERPING1/OGlyco:13
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053502 |
plasma protease C1 inhibitor O-glycosylated 14 (human)
|
hSERPING1/OGlyco:14
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-47 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-47, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053503 |
plasma protease C1 inhibitor O-glycosylated 15 (human)
|
hSERPING1/OGlyco:15
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-47 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-47, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053504 |
plasma protease C1 inhibitor O-glycosylated 16 (human)
|
hSERPING1/OGlyco:16
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-48 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-48, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053505 |
plasma protease C1 inhibitor O-glycosylated 17 (human)
|
hSERPING1/OGlyco:17
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-48 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-48, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000070326 |
plasma protease C1 inhibitor deaminated 1 (human)
|
hSERPING1/Deam:1
|
"A plasma protease C1 inhibitor (human) that has been deaminated on the residue at the position equivalent to Asn-352 of the amino acid sequence represented by UniProtKB:P05155-1. Example: UniProtKB:P05155-1, Asn-352, MOD:00684." [IEDB_epitope:1994741, PRO:DNx]
|
|
|
|
|
